HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2307
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing ; volume:457 ; number:3 ; day:28 ; month:7 ; year:2010 ; pages:299-307 ; date:9.2010
Virchows Archiv ; 457, Heft 3 (28.7.2010), 299-307, 9.2010
- Urheber
-
Rüschoff, Josef
Dietel, Manfred
Baretton, Gustavo
Arbogast, Susanne
Walch, Axel
Monges, Geneviéve
Chenard, Marie-Pierre
Penault-Llorca, Frédérique
Nagelmeier, Iris
Schlake, Werner
Höfler, H.
Kreipe, H. H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-010-0952-2
- URN
-
urn:nbn:de:101:1-2019111712185080163361
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rüschoff, Josef
- Dietel, Manfred
- Baretton, Gustavo
- Arbogast, Susanne
- Walch, Axel
- Monges, Geneviéve
- Chenard, Marie-Pierre
- Penault-Llorca, Frédérique
- Nagelmeier, Iris
- Schlake, Werner
- Höfler, H.
- Kreipe, H. H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival